Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Namrata Vijayvergia"'
Publikováno v:
Journal of Personalized Medicine, Vol 5, Iss 3, Pp 243-263 (2015)
Advances in early detection and curative therapies have led to an increased number of cancer survivors over the last twenty years. With this population comes the need to evaluate the late and long term effects of cancer treatment and develop recommen
Externí odkaz:
https://doaj.org/article/4d5546d44f3e445b928c78e0b2d1e8c6
Autor:
Eric A. Ross, Jean-Nicolas Gallant, Efrat Dotan, Harry S. Cooper, Karen Ruth, Harold A. Harvey, Miriam Kunkel, Arthur Winer, Bora Lim, Kevin P. White, Kenneth R. Korzekwa, Namrata Vijayvergia, Edward W. Wang, Jeffrey Sivik, Steven J. Cohen, Wafik S. El-Deiry, Lanlan Zhou, Igor Astaturov, Crystal S. Denlinger
Publikováno v:
Clinical Colorectal Cancer. 20:e43-e52
Background Quinacrine plus a fluoropyrimidine has in vivo efficacy against metastatic colorectal cancer (mCRC). This phase 1b trial evaluated the combination of quinacrine plus capecitabine in patients with treatment-refractory mCRC. Patients and Met
Autor:
Namrata Vijayvergia, Thomas L Holden
Publikováno v:
Current Colorectal Cancer Reports. 17:1-9
The currently established standard of care treatment for locally advanced rectal cancer (LARC) is neoadjuvant chemoradiotherapy (CRT) followed by total mesorectal excision (TME) and adjuvant fluorouracil and oxaliplatin. The body of evidence that sup
Autor:
Kerry S. Campbell, R. Katherine Alpaugh, Alexander W. MacFarlane, Ho Man Yeung, Paul F. Engstrom, Essel Dulaimi, Arvind Dasari, Namrata Vijayvergia
Publikováno v:
Cancer Immunol Immunother
High grade neuroendocrine neoplasms (G3 NENs) are rare aggressive tumors with limited treatment options. Twenty-one previously treated patients with metastatic extra-pulmonary G3 NENs were treated with pembrolizumab. Baseline tumor samples were asses
Autor:
Sonali Agrawal, William H. Ward, Caitlin R. Meeker, Efrat Dotan, Sandeep Aggarwal, Namrata Vijayvergia, Elizabeth Handorf, Jeffrey M. Farma, Sunil Adige, Crystal S. Denlinger
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:HSR20-076
Autor:
Taymeyah Al-Toubah, Steven J. Cohen, Nicole Ross, Arvind Dasari, Efrat Dotan, Paul F. Engstrom, Michael J. Hall, Melissa M. Runyen, Namrata Vijayvergia, R. Katherine Alpaugh, Jonathan R. Strosberg, Crystal S. Denlinger, Daniel M. Halperin, Mengying Deng, Samuel Litwin
Publikováno v:
British Journal of Cancer
Background Metastatic high-grade neuroendocrine neoplasms (G3NENs) have limited treatment options after progression on platinum-based therapy. We addressed the role of Pembrolizumab in patients with previously treated metastatic G3NENs. Methods Two o
Publikováno v:
JCO Oncol Pract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::933a8ed09b81496fb9df2d1b4cfc4418
https://europepmc.org/articles/PMC9014463/
https://europepmc.org/articles/PMC9014463/
Publikováno v:
The Journal of surgical research. 278
316 Background: Multidisciplinary tumor boards (TBs) are crucial for optimal decision making and management of patients diagnosed with complex malignancies. The social distancing conditions imposed by COVID-19 presented an opportunity to assess the v
Autor:
Arash Kardan, Thomas J. Giordano, Thorvardur R. Halfdanarson, Jennifer A. Chan, Lawrence S. Blaszkowsky, Christopher H. Lieu, Pamela Brock, Anthony P. Heaney, Boris W. Kuvshinoff, Satya Das, Whitney S. Goldner, Al B. Benson, Cindy Hochstetler, Beth Lynn, Heloisa P. Soares, Craig R. Sussman, Fouad Kandeel, Jin He, Daniel M. Halperin, Emily K. Bergsland, Jonathan R. Strosberg, Nataliya Uboha, Sajid A. Khan, Terence Z. Wong, Kimberly A. Miller, Michael C. Soulen, Martin J. Heslin, Venu G. Pillarisetty, Manisha H. Shah, Paxton V. Dickson, Nikolaos A. Trikalinos, Namrata Vijayvergia, Shagufta Shaheen, Diane Lauren Reidy, Sarimar N Agosto Salgado, Paul T. Fanta
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 19(7)
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients with neuroendocrine tumors (NETs), adrenal tumors, pheochromocytomas, paraga
Autor:
Elizabeth Handorf, Michael J. Hall, Joshua E. Meyer, Caitlin R. Meeker, Elin R. Sigurdson, Maureen V. Hill, William H. Ward, Crystal S. Denlinger, Igor Astsaturov, Thomas L Holden, Matthew Zibelman, Margret B. Einarson, Efrat Dotan, R. Katherine Alpaugh, Sanjay S. Reddy, Namrata Vijayvergia, Jeffrey M. Farma
Publikováno v:
JCO Clin Cancer Inform
PURPOSE Performance status (PS) is a subjective assessment of patients' overall health. Quantification of physical activity using a wearable tracker (Fitbit Charge [FC]) may provide an objective measure of patient's overall PS and treatment tolerance